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Abstract
Background: There has been considerable research into the impact of chronic illness on health-related quality of life.
However, few studies have assessed the impact of different chronic conditions on general quality of life (QOL). The objective
of this paper was to compare general (rather than health-related) QOL and affective well-being in middle aged and older
people across eight chronic illnesses.
Methods and Findings: This population-based, cross-sectional study involved 11,523 individuals aged 50 years and older,
taking part in wave 1 of the English Longitudinal Study of Ageing. General QOL was assessed using the CASP-19, happiness
was evaluated using two items drawn from the GHQ-12, and depression was measured with the CES-D. Analysis of
covariance and logistic regression, adjusting for age, gender and wealth, were performed. General QOL was most impaired
in people with stroke (mean 37.56, CI 36.73–38.39), and least in those reporting cancer (mean 41.78, CI 41.12–42.44,
respectively), compared with no illness (mean 44.15, CI 43.92–44.39). Stroke (mean 3.65, CI 3.58–3.73) was also associated
with the greatest reduction in positive well-being whereas diabetes (mean 3.81, CI 3.76–3.86) and cancer were least affected
(3.85, CI 3.79–3.91), compared with no illness (mean 3.97, CI 3.95–4.00). Depression was significantly elevated in all
conditions, but was most common in chronic lung disease (OR 3.04, CI 2.56–3.61), with more modest elevations in those
with osteoarthritis (OR 2.08, CI 1.84–2.34) or cancer (OR 2.07, CI 1.69–2.54). Multiple co-morbidities were associated with
greater decrements in QOL and affective well-being.
Conclusion: The presence of chronic illness is associated with impairments in broader aspects of QOL and affective well-
being, but different conditions vary in their impact. Further longitudinal work is needed to establish the temporal links
between chronic illness and impairments in QOL and affective well-being.
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Introduction
Quality of life (QOL) for people with chronic physical illnesses such
as cancer, diabetes and coronary heart disease (CHD), has been the
focus of a substantial body of work. However, the primary focus of
research has been on health-related quality of life (HRQOL) rather
than positive well-being or QOL in general. The aim of the present
study was to investigate the impact of chronic illness using a wider set of
QOL constructs, including measures of positive and negative affect, in
a general population sample of middle aged and older adults. The
main purpose was to establish which conditions have the most
pronounced effect, and to discover whether general QOL and affective
well-being is especially impaired in different physical illnesses.
HRQOL, however, is just one element of QOL, focusing
particularly on the functional effects of the illness and its
management on physical, mental and social function. However,
poor health does not necessarily equate poor QOL, since some
individuals are able to overcome disease-specific limitations, and
adapt their lives to pursue their goals. Previous multiple-condition
studies of HRQOL have shown that although chronic illness
typically has significant negative effects on physical aspects of
health, mental health status may remain relatively unaffected
[1–3]. Less is known about broader aspects of QOL, including
issues such as material and emotional well-being, autonomy,
self-realisation, control over important aspects of life, and mean-
ing and fulfilment [4,5]. Positive affect is another important
outcome, which has determinants and consequences that are
distinct from negative affective states [6,7]. This general concept of
QOL has seldom been assessed in relation to chronic physical
illness.
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Broader QOL is the focus in the present study, using a measure
developed for older adults from a human needs perspective, in
which QOL is seen as the satisfaction of needs in four domains,
namely control, autonomy, self-realization and pleasure [8]. The
control domain refers to people’s needs and abilities actively to
control their environments, while autonomy is defined as the right
of the individual to be free from unwanted interference of others.
Self-realization and pleasure capture the active and reflexive
processes of being human. Additionally, happiness and depressive
symptoms were assessed, so as to explore differential associations
with positive and negative affective states. The present analyses
were largely exploratory in nature; however, we broadly
hypothesised that chronic illnesses would be associated with
reduced general QOL, reduced happiness and elevated levels of
depressed mood. Multiple chronic illnesses are a particular
problem, and a recent study [9] found that people with multiple
physical co-morbidities had much poorer HRQOL and higher
levels of psychological distress. Therefore, we also hypothesised
that multiple chronic physical illnesses would be associated with
greater impairment in general QOL and affective well-being than
single health conditions, and that a cumulative effect related to the
number of chronic illnesses reported would be observed.
This study was carried out using data from the English
Longitudinal Study of Ageing (ELSA). This is a representative,
population sample of non-institutionalised men and women aged
50 years and over living in England, and includes detailed
measures of economic and social circumstances as well as health
and well-being. Embedding the study within ELSA ensured that
findings were not limited to a selected group of patients with
chronic illness, and also made it possible to utilise the detailed
measures of wealth and other indicators available in the main
study. These provide more robust indicators of socioeconomic
status (SES) in this age group than traditional indicators such as
educational attainment [10].
Methods
Participants
Data for these analyses were from wave 1 of ELSA. This
representative, population-based sample of non-institutionalised
adults was drawn from people who had previously participated in
the Health Survey for England (HSE) in 1998, 1999 or 2001 [11].
The core ELSA sample comprises adults aged 50 years or over,
and is drawn from the HSE sample by postcode sector (geographic
area), stratified by health authority and proportion of households
in non-manual socioeconomic groups. Respondents aged over the
age of 50 and living in England in 2002 were used for these cross-
sectional analyses (n = 11,523). Comparisons with census data
suggest that the ELSA sample is representative of the English
population aged 50 and over [12]. Details of the ELSA
methodology have been published previously [13], but briefly,
wave 1 involved a computer assisted personal interview during a
home visit, and a self-completion questionnaire to return by post.
The measures used in this study derive both from the home
interview and the self-completion questionnaire.
Ethics statement
Ethical approval for ELSA Wave 1 was granted from the
Multicentre Research and Ethics Committee and written informed
consent was obtained from all participants.
Measures
Demographics. Since QOL scores tend to vary with age,
gender and SES [14], these were included as covariates in all the
analyses. Age was initially recorded in exact years, but for the
purposes of the analyses, individuals were categorised into 5-year
age bands with the exception of the oldest group (50–54; 55–59;
60–64; 65–69; 70–74; 75–79; 80+). Accumulated wealth was used
as an indicator of SES, since this best represents economic
resources and is a robust measure in this age group [10]. This
variable was split into quintiles, 1 being the lowest wealth and 5
the highest wealth.
Chronic conditions. Presence of chronic illness was assessed
during the home interview, and participants responded to the
following question, ‘Has a doctor ever told you that you have (or
have had) diabetes, chronic lung disease, asthma, cancer (or
history of cancer after age 40), osteoarthritis, rheumatoid arthritis,
CHD, or stroke?’.
Quality of life and affective well-being. QOL was
measured using the CASP-19, a self-completion questionnaire
originally developed and validated in a representative UK sample
of 263 people in ‘early old age’ (65–75 years) from the Boyd-Orr
study [8]. This scale incorporates 19 Likert-scored items relating to
perceptions of control, autonomy, self-realization and pleasure
representing broad aspects of QOL. The first letter of each
domain and its 19 items create the acronym CASP-19 that names
the measure. Respondents indicate the degree to which each item
applies to them on a scale of ‘never’ (scored 0) to ‘often’ (scored 3),
to give a total score out of 57, with higher scores corresponding to
better QOL. Representative items include ‘I can do the things I
want to do’, ‘I look forward to each day’, ‘I enjoy the things that I
do’ and ‘I feel satisfied with the way my life has turned out’. The
focus on general aspects of QOL provides distinctive information
from health-focused instruments, and the same measure has been
used in the Health and Retirement Study (HRS), the Health,
Alcohol and Psychosocial factors In Eastern Europe (HAPIEE)
study, and the Swedish Longitudinal Occupational Survey of
Health (SLOSH). The CASP-19 has been developed as a measure
of quality of life in older adults, and a number of studies
demonstrate its validity [8]. The Cronbach’s a for the CASP-19 in
this study was 0.88.
Affective well-being was quantified both in terms of happiness
and depression. Respondents completed the 12-item General
Health Questionnaire (GHQ-12) [15], a widely used and
extensively validated measure both in general and clinical
populations worldwide [16]. Happiness was measured with two
items drawn from this questionnaire, namely ‘Have you recently
been able to enjoy your normal day-to-day activities?’ and
‘Have you recently been feeling reasonably happy, all things
considered?’. Each item was rated on a four-point scale
(much less than usual, less so than usual, about the same as usual,
or more so than usual). For the purpose of these analyses these
two items were combined and responses were rated on a
continuous scale ranging from 0 to 6, with higher scores indicating
higher levels of happiness. The Chronbach’s a for this measure
was 0.92.
Depressive symptoms were assessed using the Centre for
Epidemiologic Studies Depression Scale (CES-D) [17]. A
shortened 8-item version with binary response options which
was developed for the HRS was used, as described by Steffick [18].
Items refer to the degree to which respondents have experien-
ced depressive symptoms over the past week. Scores range
from 0 to 8, with higher scores indicating greater depressive
symptoms. The present analyses dichotomised CES-D scores
above and below 4, a well-established threshold for indicating the
presence or absence of depressed mood [18]. In the present sample
the CES-D demonstrated good internal reliability (Cronbach’s
a=0.80).
Quality of Life in Chronic Illness
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Statistical analyses
Standard descriptive statistics were used to describe sample
characteristics, chronic conditions, QOL and affective well-being.
In order to examine whether the eight chronic conditions were
associated with differences in affective well-being and general
QOL, analysis of covariance was conducted on QOL and
happiness ratings, and logistic regressions on depressed mood.
Results are presented as means and odds ratios (OR) with 95%
confidence intervals (CI) or percentages (%), adjusting for age,
gender, and wealth. To protect against spurious results arising
from multiple testing, Bonferroni estimates led to setting statistical
significance at a p-value of ,0.005. The associations of multiple
chronic illnesses with QOL and well-being were analysed by
categorising people into zero, one, two, three and four or more
conditions, and carrying out analysis of covariance on CASP-19
and happiness ratings, and logistic regression on depressed mood.
Results
Table 1 presents the sample characteristics. The average age of
the 11,523 participants included in these analyses was 65.14
(SD 10.47) years, and just over half (54.6%) were women. Complete
data on CASP-19 were available for 9,407 participants, happiness
ratings were obtained from 10,266 participants, and CES-D scores
from 11,063 individuals (representing 82%, 89% and 96% of the
sample, respectively). There were marked differences in QOL and
affect by age, gender and SES (wealth). The oldest age groups (75–
79 and 80+years) had significantly lower CASP-19 scores than the
younger age groups (p,0.001), indicating poorer QOL, while
women had slightly higher scores than men (mean 42.75, SD 8.67
and, mean 42.21, SD 8.71, respectively). A significant linear
association was observed for wealth quintiles, with CASP-19 scores
falling from 45.65 (SD 8.70) for the highest quintile to 37.85 (SD
9.44) for the lowest quintile (p,0.001). Depression also varied with
age, gender and wealth, with the oldest age groups (70 years and
older), women, and those in the bottom two wealth quintiles being
significantly more likely to report depressed mood (all at p,0.001).
The oldest age group (80+) was less happy than all other age groups
(p,0.001). There were no gender differences in happiness ratings
(p= 0.75), but those in the lower wealth quintiles reported
significantly lower happiness ratings than those in the higher wealth
quintiles (p,0.001).
Incidence of chronic illness
Almost half of respondents reported at least one chronic
condition (Table 1), a comparable rate to that observed in other
national surveys including this age range [19]. Osteoarthritis was
the most common (18.9%) followed by CHD (12.3%), with stroke
and cancer being the least common conditions (4.4% and 5.9%,
respectively). Of the 11,523 participants included in these analyses,
3839 (33.3%) reported at least one of the nine conditions, 1445
(12.5%) had two conditions, 417 (3.6%) reported three conditions,
113 (1.0%) had four conditions, and 23 (0.2%) reported five or
more co-morbid conditions.
General quality of life and affective well-being
There was significantly reduced QOL for each of the eight
chronic illnesses (diabetes, lung disease, asthma, cancer, osteoar-
thritis, rheumatoid arthritis, CHD, stroke), compared with not
having any condition (Table 2), adjusting for age, gender, and
wealth (all at p,0.005). These findings are illustrated in Figure 1,
and indicate that stroke victims had the poorest QOL, followed by
chronic lung disease (mean 37.56, CI 36.73–38.39, and mean
38.70, CI 38.07–39.33, respectively). People with rheumatoid
arthritis showed similar limitations in QOL as those with CHD,
closely followed by diabetes and asthma. QOL was impaired least
in people with osteoarthritis and cancer.
All eight conditions were associated with significantly reduced
happiness ratings (all at p,0.005), controlling for age, gender and
wealth (Table 2). People who had had a stroke reported the lowest
levels of happiness (mean 3.65, CI 3.58–3.73), followed by those
with chronic lung disease, CHD, osteoarthritis and rheumatoid
arthritis. People with asthma had similar happiness ratings as those
with diabetes. Happiness ratings were least affected in respondents
with cancer (mean 3.85, CI 3.79–3.91). These findings are
illustrated in Figure 2.
The proportion of respondents not suffering from any chronic
illness who were defined as having depressed mood was 18.5%.
The proportion of respondents who were depressed was
substantially elevated in all chronic illnesses, controlling for age,
gender, and wealth. These findings are illustrated in Figure 3. The
highest levels of depression were observed in people with chronic
lung disease or stroke who had approximately three times the odds
of reporting depressed mood as those without any illness (OR 3.04,
CI 2.56–3.61 and, OR 2.94, CI 2.37–3.64, respectively). People
with osteoarthritis and cancer had the lowest increased odds
for depressed mood (OR 2.08, CI 1.84–2.34 and, OR 2.07, CI
1.69–2.54, respectively) (Table 2).
Multiple chronic conditions, quality of life and affective
well-being
Adjusting for age, gender and wealth, a significant linear trend
was observed across groups in QOL (f (4, 9216) = 148.15, p,0.001,
g2 = 0.06) with scores decreasing from 44.19 (CI 43.96–44.42) in
the no illness group to 34.78 (CI 33.18–36.39) in respondents with
four or more co-morbid conditions (Figure 4-a). Similarly, a linear
trend for happiness ratings was observed (f (4, 10059) = 44.76,
p,0.001, g2 = 0.02), with mean values ranging from 3.98
(CI 3.95–4.00) in respondents with no chronic illness to 3.52
(CI 3.37–3.66) in people with four or more conditions (Figure 4-b).
However, having three and four or more co-morbid conditions
was not associated with significantly worse happiness ratings than
were happiness ratings for those with only two co-morbid
conditions. Participants with four or more conditions had more
than six-fold odds of reporting depressed mood than people with
no chronic illness (OR 6.28, CI 4.34–9.08), after controlling for
age, gender and wealth. People with three co-morbid chronic
illnesses had more than a three-fold increased risk of depressed
mood compared with those with no chronic illness (OR 3.66,
CI 2.94–4.55). The odds of reporting depressed mood among
people with two conditions were 2.66 (CI 2.32–3.04) and the odds
of depressed mood in those respondents with one condition only
were 1.57 (CI 1.41–1.75) (The percentage of depressed mood by
number of chronic conditions is shown in Figure 4-c).
Discussion
Overall QOL is more than just the presence or absence of
disease. Specific functional impairments as measured in HRQOL
assessments are likely to contribute to general QOL and affective
well-being, but many other factors will be relevant including social
and material circumstances, ability to fulfil ambitions, and
constraints on opportunities and choice. Assessments of compo-
nents that constitute general QOL, such as well-being, self-
realisation, pleasure, sense of control and autonomy are scarce. In
this paper, we studied the association of eight different chronic
conditions with general QOL, happiness and depressed mood, in a
population-based sample. This study adds to the literature by
Quality of Life in Chronic Illness
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comparing several conditions while accounting for demographic
and social factors. Studying several chronic conditions simulta-
neously is an essential step towards developing a capacity to assess
and rank various chronic diseases for the purpose of prevention
and intervention programmes and resource allocation. Assessment
of QOL is important in the public health setting. Trends in health
expectancies are changing, and contrasting evidence suggest on
the one hand that compression of morbidity and a decline in
disability in older age has occurred [20,21], and on the other, an
expansion of years of life accompanied by morbidity and function
loss [22]. As the population ages, the preservation of QOL in later
life is becoming a key policy issue. We found that having a chronic
illness was associated with significantly reduced QOL and affective
well-being compared with a no disease group, controlling for
differences in age, gender and wealth. However, the impact of
different illnesses varied, and the ranking of illnesses on the three
indicators of QOL and affective well-being was not the same. The
findings therefore argue for a more nuanced approach to
Table 1. Participant characteristics.
Total
sample
Quality of life
(mean, SD)1
Happiness
(mean, SD)2
Depression
(% yes)3
Demographics
Mean age (SD) 65.14 (10.47)
Age, %
50–54 2074 (18.0) 43.10 (8.62) 3.90 (0.84) 452 (22.3)
55–59 2202 (19.1) 42.86 (8.79) 3.90 (0.83) 483 (22.6)
60–64 1696 (14.7) 43.32 (8.58) 3.93 (0.81) 355 (21.8)
65–69 1718 (14.9) 43.15 (8.44) 3.96 (0.67) 366 (22.1)
70–74 1477 (12.8) 42.58 (8.39) 3.90 (0.77) 355 (24.9)
75–79 1094 (9.5) 41.06 (8.68) 3.86 (0.82) 302 (29.0)
80+ 1262 (11.0) 38.83 (8.67) 3.74 (0.86) 379 (33.0)
Gender, %
Male 5231 (45.4) 42.21 (8.71) 3.90 (0.79) 1002 (20.0)
Female 6292 (54.6) 42.75 (8.67) 3.89 (0.81) 1690 (28.0)
SES (Wealth), %
Lowest - 1 2192 (19.4) 37.85 (9.44) 3.73 (0.98) 825 (39.7)
2 2262 (20.0) 40.77 (9.12) 3.82 (0.91) 639 (29.6)
3 2265 (20.1) 42.76 (8.10) 3.93 (0.74) 498 (22.8)
4 2253 (20.0) 44.02 (7.69) 3.97 (0.67) 378 (17.3)
Highest - 5 2321 (20.6) 45.65 (8.70) 4.00 (0.67) 311 (13.9)
Chronic conditions
No condition, % 5686 (49.3)
Diabetes, % 853 (7.4)
Chronic lung disease, % 749 (6.5)
Asthma, % 1346 (11.7)
Cancer, % 676 (5.9)
Osteoarthritis, % 2183 (18.9)
Rheumatoid arthritis, % 818 (7.1)
Coronary heart disease, % 1416 (12.3)
Stroke, % 509 (4.4)
Quality of life and affective well-being
Mean quality of life (SD) 42.50 (8.69)
Mean happiness (SD) 3.89 (0.80)
Depression, %
Yes 2692 (24.3)
No 8371 (75.7)
Mean (Standard deviation [SD]) and N (%).
1Quality of life assessed using CASP-19. Scores could range from 0 to 57.
2Happiness assessed using two items drawn from the GHQ-12, namely ‘Have you recently been able to enjoy your normal day-to-day activities?’ and ‘Have you recently
been feeling reasonably happy, all things considered?’. Scores could range from 0 to 6.
3Depression was assessed using the CES-D. Scores could range from 0 to 8. Total scores =.4 indicate presence of depressed mood (yes), scores =,3 indicate absence
of depressed mood (no).
SES = Socioeconomic status.
doi:10.1371/journal.pone.0018952.t001
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understanding the impact of chronic illness on the well-being of
middle aged and older people.
Previous research has focused largely on HRQOL, using
measures such as the Medical Outcomes Study Short Form-36
(SF-36) [23]. Generic HRQOL measures such as this have the
advantage of permitting comparisons across chronic illnesses,
which is important both for understanding adaptation to different
conditions and for resource allocation [24]. A growing body of
research has examined HRQOL across a variety of diseases, and
many studies have identified significant impairments [25–32]. In a
population study of over 6000 participants, Hobbs et al [28]
compared patients with heart failure, angina, myocardial infarc-
tion, hypertension, arthritis and chronic bronchitis. People with
heart failure had the poorest HRQOL across most domains,
though patients with chronic lung diseases and arthritis also
reported poor HRQOL, and people with hypertension had only
slight impairments. In the present study, stroke, chronic lung
disease (mainly chronic bronchitis and emphysema) and rheuma-
toid arthritis were associated with the greatest impairments in
general QOL and lower positive affect.
A more recent study examined HRQOL in a sample of over
40,000 US army veterans [27]. Presence of diabetes, chronic
obstructive pulmonary disease, heart problems, hypertension or
arthritis, was associated with significantly lower scores on the
Table 2. Quality of life and affective well-being for each illness compared with having no chronic illness.
Quality of life Happiness ratings Depressed mood
Chronic condition n Mean (95% CI)* n Mean (95% CI)* n % depressed OR (95% CI)*
No condition 4665 44.15 (43.92–44.39) 4992 3.97 (3.95–4.00) 5364 18.5% Reference group
Cancer 529 41.68 (41.03–42.33) 580 3.85 (3.79–3.91) 630 29.0% 2.07 (1.69–2.54)
Osteoarthritis 1750 40.56 (40.18–40.93) 1943 3.75 (3.71–3.78) 2085 31.3% 2.08 (1.84–2.34)
Asthma 1072 40.35 (39.88–40.82) 1175 3.80 (3.76–3.84) 1261 33.5% 2.37 (2.06–2.73)
Diabetes 620 40.24 (39.63–40.85) 715 3.81 (3.76–3.86) 791 33.1% 2.35 (1.98–2.79)
Coronary heart disease 1079 39.59 (39.10–40.08) 1228 3.73 (3.69–3.78) 1334 34.1% 2.44 (2.11–2.83)
Rheumatoid arthritis 614 39.43 (38.81–40.04) 697 3.79 (3.73–3.84) 767 38.1% 2.82 (2.39–3.33)
Chronic lung disease 585 38.70 (38.07–39.33) 659 3.72 (3.66–3.78) 717 39.7% 3.04 (2.56–3.61)
Stroke 345 37.56 (36.73–38.39) 398 3.65 (3.58–3.73) 455 38.4% 2.94 (2.37–3.64)
*Adjusted for age, gender and wealth. All values at p,0.005.
doi:10.1371/journal.pone.0018952.t002
Figure 1. Quality of life scores adjusted for age, gender, and wealth. Mean quality of life scores (95% CI) as measured by the CASP-19,
adjusted for age, gender and wealth for respondents with no chronic condition and for all eight chronic conditions. Higher scores indicate better
QOL.
doi:10.1371/journal.pone.0018952.g001
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physical component summary (PCS) and mental component
summary (MCS) of the SF-36. HRQOL differences were more
pronounced for the PCS than the MCS in this study, suggesting
that although veterans have greater physical and mental HRQOL
impairments than the general US population, physical HRQOL is
more affected. Chronic lung disease and arthritis were associated
with the greatest impairments in HRQOL, whereas scores were
only modestly reduced in those with diabetes or hypertension. In
Figure 2. Happiness ratings adjusted for age, gender, and wealth. Mean happiness ratings (95% CI) adjusted for age, gender and wealth for
respondents with no chronic condition and for all eight conditions. Higher scores indicate greater happiness.
doi:10.1371/journal.pone.0018952.g002
Figure 3. Percentage depressed mood adjusted for age, gender, and wealth. Percentage of depressed mood (95% CI), adjusted for age,
gender and wealth, for respondents with no condition and for all eight chronic conditions. Higher scores indicate greater depressed mood.
doi:10.1371/journal.pone.0018952.g003
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our study, diabetes was also associated with somewhat reduced
general QOL and happiness ratings, and moderately elevated
levels of depressed mood. Other studies have also shown that
impact of diabetes on HRQOL is intermediate, relative to other
chronic medical conditions [1] and that the effect is more
pronounced on the physical relative to the mental health
components of the SF-36 [33]. However, these findings are not
surprising considering the ‘silent’ nature of illnesses such as
diabetes. Using the SF-36, Lyons and colleagues [26] found that,
after controlling for age and gender, all patient groups (asthma,
diabetes, arthritis, back pain, sciatica, hypertension, angina,
myocardial infarction and stroke) had significantly poorer
HRQOL than did those without the condition across all the
HRQOL domains. In our study, there was also a clear relationship
between the number of illnesses and general QOL and well-being,
since respondents with multiple chronic conditions had signifi-
cantly reduced QOL and impaired affective well-being. Previous
studies have shown multiple co-morbidities to be associated with
feeling unhappy and being more psychologically distressed [9,34]
and that effects may be additive [33].
One explanation for why some chronic illnesses included in the
present study have greater impact on QOL and affective well-
being than others may be related to the threat to survival. But the
impact on well-being was not simply graded by mortality risk,
making it likely that some combination of specific impairments
related to these conditions and effects on social activities and
fulfilment of aspirations also influenced QOL and affective well-
being. The significance of these differences in general QOL and
affective well-being across conditions for prognosis and illness
management may vary. For example, there is strong evidence that
depression in patients with CHD is a predictor of recurrent cardiac
events and premature mortality [35]. Recent meta-analyses also
argue that depression is associated with accelerated mortality in
people who have experienced cancer [36,37]. So even though
depression levels were not as high in these conditions as some of
the other illnesses tested, modest elevations may nonetheless be
important. Less is known about the effects of positive affect on
survival in patients with chronic illnesses [6]. More generally,
Katon et al [38] have concluded that symptoms of depression and
anxiety are associated with greater symptom burden (net of
objective disease severity) in a variety of conditions, including
chronic lung disease, diabetes, heart disease and arthritis,
suggesting that the patterns described here are relevant to
adaptation. The relatively modest impact of cancer on psycho-
logical distress and general QOL is notable, given the attention
that has been focused on these issues in cancer patients [39].
However, it is important to note that the stage of cancer was
unknown and that respondents in the present study may have had
cancer some years ago, although childhood and young adulthood
cancers were excluded. One possible explanation is that benefit
finding is prominent among patients with cancer, and may offset in
part the negative impact of the condition [40]. Additionally, the
types of cancer reported by participants varied widely in this study,
and some may have a more adverse impact on QOL and affective
well-being than others.
The strengths of this study include the use of a large nationally
representative sample of non-institutionalised respondents experi-
encing a wide range of chronic conditions. Another feature of this
study was the use of well-validated measures of general QOL,
focusing on broad aspects of QOL rather than on symptomatic
and functional impairments, and measures of positive and negative
affect to assess affective well-being. Another strength of the study
was the high participation rate (.80% for all measures). However,
there are some limitations that must be considered. We used the
CASP-19 to assess general QOL. Although this measure has been
used extensively, the factorial structure remains controversial and
alternative versions have been developed [41]. The clinical
significance of the differences in general QOL and happiness is
not known, since minimal important differences for these measures
have not been established. The study was cross-sectional, so causal
inferences cannot be drawn. Identification of chronic medical
conditions were based on self-report of having been told of the
illness by a doctor, which may not be as accurate as physician
diagnoses. However, reliability of self-report has been found to be
acceptable for conditions that require medical or laboratory
diagnostic procedures [42–44]. In addition, our analyses did not
account for how long these illnesses had been present, or the
varying degrees of severity. Duration or onset of illness may have a
particular impact on QOL reports, as it seems people continually
adapt to their illness. Levels of subjective well-being seem to be
especially sensitive to adaptation after the onset of chronic medical
conditions. For example, people who might be expected to feel
despair given their physical health often report being happier and
more satisfied with life than would be expected. Response shift
theory [45,46] postulates that when individuals experience a
change in their health status, they may also change their
appraisals, internal standards and values regarding QOL. Future
work would benefit from considering the influence of response
Figure 4. Co-morbidity and quality of life (a), happiness (b) and depressed mood (c). Panel (a) shows the mean quality of life scores (95%
CI) for respondents with one, two, three and four or more conditions compared with those without a chronic condition, adjusted for age, gender and
wealth. Higher scores indicate better QOL. Panel (b) shows the mean happiness ratings (95% CI) for respondents with no condition compared with
one, two, three and four or more co-morbid chronic conditions, adjusted for age, gender and wealth. Higher scores indicate greater happiness. Panel
(c) show the percentage of depressed mood, adjusted for age, gender and wealth, for respondents with one, two, three and four or more co-morbid
conditions compared with those respondents with no chronic condition.
doi:10.1371/journal.pone.0018952.g004
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shifts to accurately assess the impact of illness on QOL. Another
issue is that the categorisation of chronic illnesses may have
disguised important variations. For example, although information
was available about different types of cancer, numbers were too
small to analyse them separately, so all malignancies were placed
in a single category. Additionally, the measure of positive affect
was derived from an established index of psychological distress, so
was not ideal and likely underestimated the levels of positive affect.
Furthermore, selection of illnesses for inclusion in the analyses was
based information available in the dataset. Finally, the presence of
co-morbidity complicates the question how a specific condition is
related to outcome variables such as affect or QOL, and our co-
morbidity analyses were performed on a simple count of illnesses
rather than on specific disease combinations. Thus, the complex
interactions that exist between these chronic conditions have not
been accounted for in the present study.
Despite these limitations, the results from this study show that
presence of chronic illness is associated with substantially reduced
general QOL and happiness, and greater levels of depressed mood
across a wide range of conditions suggesting that the presence of
chronic illness is not limited to function related impairments only
but may have broader implications. Although illnesses associated
with significant functional impairment or pain (such as stroke,
rheumatoid arthritis and chronic lung disease) were characterized
by low mood, low positive affect and poor QOL, it is notable that
levels of happiness were not greatly impaired in those with cancer,
and only modestly impaired in those with diabetes, asthma or
rheumatoid arthritis. These findings suggest that measures of
positive affect may reveal subtle effects of physical illness that are
not addressed by other measures of well-being and attention
should be directed to examination of reduced positive affect as well
as negative affective states such as depression. Further longitudinal
work is needed to establish the temporal links between chronic
illness and impairment in QOL and positive well-being.
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